Chantale Bernatchez Selected Research

Small Cytoplasmic RNA

11/2021	Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.
11/2018	A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chantale Bernatchez Research Topics

Disease

75	Neoplasms (Cancer) 05/2024 - 04/2011
44	Melanoma (Melanoma, Malignant) 02/2024 - 04/2011
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2018
8	Lung Neoplasms (Lung Cancer) 10/2021 - 01/2016
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
3	Adenocarcinoma 11/2021 - 12/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 01/2019
2	Adenocarcinoma of Lung 01/2021 - 10/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2020
2	Triple Negative Breast Neoplasms 05/2019 - 10/2018
2	Uveal melanoma 11/2018 - 01/2017
2	Grover's disease 01/2017 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 10/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024
1	Overweight 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Colitis 01/2022
1	Chordoma 01/2022
1	Hemangiosarcoma (Angiosarcoma) 01/2022
1	Synovial Sarcoma (Synovioma) 01/2022
1	Alveolar Soft Part Sarcoma 01/2022
1	Leiomyosarcoma 01/2022
1	Liposarcoma 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 10/2021
1	Urinary Retention 09/2021
1	Pathologic Complete Response 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Paraganglioma (Paragangliomas) 01/2020
1	Pheochromocytoma 01/2020
1	Ovarian Epithelial Carcinoma 11/2019

Drug/Important Bio-Agent (IBA)

14	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2016
12	AntigensIBA 10/2021 - 04/2011
11	RNA (Ribonucleic Acid)IBA 05/2024 - 09/2012
9	Interleukin-2 (IL2)IBA 02/2024 - 04/2011
7	Peptides (Polypeptides)IBA 01/2021 - 12/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
5	AntibodiesIBA 01/2022 - 04/2011
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 03/2012
5	IpilimumabIBA 01/2021 - 01/2016
4	LigandsIBA 11/2021 - 10/2012
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 04/2011
4	CytokinesIBA 01/2020 - 02/2016
4	bempegaldesleukinIBA 01/2020 - 01/2019
4	pembrolizumabIBA 01/2020 - 01/2016
3	Chimeric Antigen ReceptorsIBA 05/2024 - 03/2012
3	Messenger RNA (mRNA)IBA 10/2021 - 01/2017
3	NivolumabIBA 01/2021 - 01/2019
3	ParaffinIBA 01/2021 - 10/2017
3	Formaldehyde (Formol)FDA Link 01/2021 - 10/2017
3	VaccinesIBA 01/2019 - 04/2011
2	urelumabIBA 02/2024 - 01/2022
2	tilsotolimodIBA 12/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2021
2	durvalumabIBA 01/2022 - 01/2021
2	tremelimumabIBA 01/2022 - 01/2021
2	Small Cytoplasmic RNAIBA 11/2021 - 11/2018
2	Immune Checkpoint ProteinsIBA 10/2021 - 01/2016
2	Keratins (Keratin)IBA 10/2021 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2017
2	HLA-A Antigens (HLA-A)IBA 01/2018 - 01/2017
2	Interleukin-12 (IL 12)IBA 01/2018 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2017
2	EpitopesIBA 01/2018 - 01/2017
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2012 - 04/2011
1	axicabtagene ciloleucelIBA 05/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	CarbonIBA 01/2023
1	InterleukinsIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	AutoantigensIBA 10/2021
1	Oxygen (Dioxygen)IBA 09/2021
1	Aurora KinasesIBA 04/2021
1	16S Ribosomal RNAIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	ChromatinIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Toll-Like Receptor 9IBA 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Polycomb Repressive Complex 2IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 12/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2019

Therapy/Procedure

49	Therapeutics 02/2024 - 04/2011
36	Immunotherapy 12/2022 - 04/2011
9	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 04/2012
7	Drug Therapy (Chemotherapy) 02/2024 - 04/2012
2	Aftercare (After-Treatment) 05/2024 - 12/2022
2	Ligation 10/2023 - 04/2011
2	Precision Medicine 11/2021 - 01/2017
1	Chest Tubes (Chest Tube) 09/2021
1	Blood Transfusion (Blood Transfusions) 09/2021